Cargando…
D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
BACKGROUND: Patients with locally advanced resectable gastric cancers are increasingly offered neoadjuvant chemotherapy (NACT) following the MAGIC and REAL-2 trials. However, information on the toxicity of NACT, its effects on perioperative surgical outcomes and tumor response is not widely reported...
Autores principales: | Shrikhande, Shailesh V, Barreto, Savio G, Talole, Sanjay D, Vinchurkar, Kumar, Annaiah, Somashekar, Suradkar, Kunal, Mehta, Shaesta, Goel, Mahesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583696/ https://www.ncbi.nlm.nih.gov/pubmed/23375104 http://dx.doi.org/10.1186/1477-7819-11-31 |
Ejemplares similares
-
Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
por: Sirohi, Bhawna, et al.
Publicado: (2014) -
Urachal Carcinoma: Are Lymphadenectomy and Umbilectomy Necessary?
por: Jia, Zhuo, et al.
Publicado: (2020) -
Tumors of the Pancreatic Body and Tail
por: Barreto, Savio George, et al.
Publicado: (2010) -
Global Perceptions on ERAS(®) in Pancreatoduodenectomy
por: Karunakaran, Monish, et al.
Publicado: (2023) -
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
por: Sirohi, Bhawna, et al.
Publicado: (2016)